COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,551 Articles (22,881 medRxiv, 8,670 bioRxiv)

Most recent first Previous |  Page 1804: Articles 18031-18040  | Next

An integrated framework for building trustworthy data-driven epidemiological models: Application to the COVID-19 outbreak in New York City
Zhang, S., Ponce, J., Zhang, Z., Lin, G., Karniadakis, G. E.
10.1101/2021.02.22.21252255 — Posted: 2021-02-24
Impact of the Tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns
Laydon, D. J., Mishra, S., Hinsley, W. R., Samartsidis, P., Flaxman, S., Gandy, A., Ferguson, N. M., Bhatt, S.
10.1101/2021.02.23.21252277 — Posted: 2021-02-24
SARS-CoV-2 genomic surveillance identifies naturally occurring truncations of ORF7a that limit immune suppression
Nemudryi, A. A., Nemudraia, A. A., Wiegand, T., Nichols, J., Snyder, D. T., Hedges, J. F., Cicha, C., Lee, H. H., Vanderwood, K. K., Bimczok, D., Jutila, M. A., Wiedenheft, B. A.
10.1101/2021.02.22.21252253 — Posted: 2021-02-24
Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study
Hamilton, A. C., Donnelly, D. W., Loughrey, M. B., Turkington, R. C., Fox, C., Fitzpatrick, D., O'Neill, C. E., Gavin, A. T., Coleman, H. G.
10.1101/2021.02.23.21252276 — Posted: 2021-02-24
The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation
Meyers, J., Ramanathan, M., Shanderson, R., Donohue, L., Ferguson, I., Guo, M., Rao, D., Miao, W., Reynolds, D., Yang, X., Zhao, Y., Yang, Y.-Y., Wang, Y., Khavari, P.
10.1101/2021.02.23.432450 — Posted: 2021-02-23
A Second Wave? What Do People Mean By COVID Waves?- A Working Definition of Epidemic Waves
Zhang, S. X., Arroyo Marioli, F., Gao, R.
10.1101/2021.02.21.21252147 — Posted: 2021-02-23
Rapid SARS-CoV-2 variants spread detected in France using specific RT-PCR testing
Haim-Boukobza, S., Trombert-Paolantoni, S., Roquebert, B., Lecorche, E., Verdurme, L., Foulongne, V., Selinger, C., Michalakis, Y., Sofonea, M. T., Alizon, S.
10.1101/2021.02.20.21251927 — Posted: 2021-02-23
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
Nambulli, S., Xiang, Y., Tilston-Lunel, N. L., Rennick, L. J., Sang, Z., Klimstra, W. B., Reed, D. S., Crossland, N. A., Shi, Y., Duprex, P. W.
10.1101/2021.02.23.432569 — Posted: 2021-02-23
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.
Goswami, R., Russell, V. S., Tu, J. J., Hughes, P., Kelly, F., Langel, S. N., Steppe, J., Palmer, S. M., Haystead, T., Blasi, M., Permar, S. R.
10.1101/2021.02.23.432479 — Posted: 2021-02-23
Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection
Bottino, D., Hather, G., Yuan, L., Stoddard, M., White, L., Chakravarty, A.
10.1101/2021.02.22.432379 — Posted: 2021-02-23 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).